Iloprost structure
Iloprost
This more chemically and biologically stable derivativeof prostacyclin is available as a solution (10 μg/mL)for nasal inhalation (Ventavis by Actelion) via a preciselycalibrated inhalation device for the treatment of pulmonaryarterial hypertension (PAH). Patients inhale 6 to 8 puffs ofaerosolized iloprost every 2 to 3 hours to produce a directvasodilatory effect on pulmonary blood vessels, therebydecreasing vascular resistance. Side effects of coughing,flushing, headaches, and jaw pain have been most commonlyreported.
Find 7 Related Holders
MSN LABORATORIES PRIVATE LTD
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
EUROAPI Hungary Ltd
United States
United States
API Registration Country
API Active
-
Country:
United States -
Email:
Bayer Ag
Finland
Finland
API Registration Country
API Active
-
Founded in:
1989-10-05 00:00:00 -
Country:
Finland
YS LIFE SCIENCE CO LTD
United States
United States
API Registration Country
API Active
CHIROGATE INTERNATIONAL INC
United States
United States
API Registration Country
API Active
SCHERING A.G.
Brazil
Brazil
API Registration Country
API Inactive
-
Country:
Brazil -
Address:
POSTFACH 650311,BELIN 65, EXTERIOR - EX -
Email:
EuroAPI Shanghai Ltd.
China
China
API Registration Country
Excipients Inactive
-
Founded in:
2021-04-29 -
Country:
China -
Address:
Room 26033, 26th Floor, No. 168, Hubin Road, Huangpu District, Shanghai (actual floor: 22nd Floor) -
Tax NO.:
91310000MA1FPLT19Y -
Registered Funds:
80,000 yuan -
Email:
Recommended Suppliers of Iloprost
-
Guangzhou Yaoguang Technology Co., Ltd.
CN1 YR
Contact Supplier -
Hangzhou Dawn Ray Pharmaceutical Co.,Ltd
CN1 YR
Contact Supplier -
JHECHEM CO LTD
CN1 YR
Contact Supplier -
CHEMLYTE SOLUTIONS CO.,LTD
CN1 YR
Contact Supplier -
Hangzhou Chungyo Chemicals Co., Ltd.
CN1 YR
Contact Supplier